Syed Muneer Ali Shah, MBBS (PK)
President
Syed is a qualified international medical professional and has been working as an insurance paramedical examiner with several clinical laboratories in Canada including Dynacare, Hooper Holmes, and ExamOne for over 20 years. Syed also leads the Ontario Chapter of International Maternal and Child Health Foundation. Syed’s has been influential in training and placing hundreds of international medical graduates in the fields of sonography, clinical labs, and medical offices.
Umbreen Akhtar, MBBS (PK), CCRP (York U.), PGD Epidemiology (France), AFS Critical Care (France)
Chief Executive Officer / Academic Director
Umbreen is a qualified intensivist completing her medical graduation in 2003. She has worked in several countries including France and Canada as a health professional. She is currently working as an insurance paramedical examiner. She is currently the program director of the Field Health Examiner Program.
Syed Uzair Ghani Irfan MBBS, MBA
Coordinator/ Consultant
Syed Uzair is a qualified international health professional with a management background. He has been involved in establishing several enterprises internationally. He holds membership of various international professional associations in his areas of expertise and traveled around the globe in over six continents in pursuance of his career. His publications include research and clinical studies on Hepatitis and Vaccination. He has also written various training and human resource development manuals, situation analysis of social & health conditions and strategic papers on organizational development.
Our Faculty
Dr. Syed Tajamul Hussain, MBBS, MCPS
Director Pharmacovigilance Programs
Dr. Hussain is a medical doctor with more than 24 years of experience in pharmaceutical R&D and Medical Affairs. Dr.Hussain is well known and respected as a knowledgeable and experienced medical affairs physician/senior executive providing medical, pharmaceutical and device (FDA-CDER, CBER, EMA, ROW etc.) guidance. His research & development direction is in the context of applicable business strategy and commercial considerations with full GCP/GMP integrity and evidence-based product development. Dr.Hussain’s positions routinely have included membership in senior business and Global management teams with overall Medical Affairs Project responsibility and authority. Past positions have also focused on overall clinical, Medical Affairs, Regulatory and Project Management responsibilities. He has a long, distinguished record of drug development with three successful IND’s, Phase 1-4 trials, NDA’s, a NDA’s, LCM, PBRERs/PSURs with GMA contribution and multiple product approvals. Experience has been global in the span of control, in global companies and has included extensive international responsibilities including harmonisation of medical-marketing and regulatory functions applying ICH and other guidelines.
